Molecular study of CEPBA in familial hematological malignancies

Familial Cancer

Volumn 8, Issue 4, 2009, Pages 581-584

  Abed, R El ^a   Bourdon, V ^b   Huiart, L ^b   Eisinger, F ^b   Khelif, A ^c   Frenay, M ^d   Gesta, P ^e   Demange, L ^f   Dreyfus, H ^g   Bonadona, V ^h   Dugast, C ⁱ   Zattara, H ^j   Faivre, L ^k   Noguchi, T ^b   Sauvan, R ^b   Soua, Z ^a   Sobol, H ^b  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b AIX MARSEILLE UNIVERSITY   (France)

^c FARHAT HACHED HOSPITAL   (Tunisia)

^d CENTRE ANTOINE LACASSAGNE   (France)

^e CHG Niort   (France)

^f Polyclinique de Courlancy   (France)

^g Institut Ste Catherine   (France)

^h CENTRE LÉON BÉRARD   (France)

ⁱ CENTRE EUGÈNE MARQUIS   (France)

^j TIMONE HOSPITAL   (France)

^k Medical University of Dijon   (France)

more..

Author keywords

CEBPA; Germline mutation; Haematological familial malignancies

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CEPBA GENE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FAMILIAL CANCER; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GERM CELL; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RUNX1 GENE; SEQUENCE ANALYSIS; ADULT; AMINO ACID SEQUENCE; BLOOD DISEASE; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, HUMAN;

ADULT; AMINO ACID SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HEMATOLOGIC NEOPLASMS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

EID: 70449427713     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-009-9289-x     Document Type: Article

References (16)

1. O Fuchs 2007 Growth-inhibiting activity of transcription factor C/EBPalpha, its role in haematopoiesis and its tumour suppressor or oncogenic properties in leukaemias Folia Biol (Praha) 53 3 97 108 1:STN:280: DC%2BD2szmsFGntQ%3D%3D
2. S Frohling RF Schlenk I Stolze, et al. 2004 CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations J Clin Oncol 22 4 624 633 10.1200/JCO.2004.06.060 14726504 (Pubitemid 41095065)
3. DE Zhang P Zhang ND Wang CJ Hetherington GJ Darlington DG Tenen 1997 Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice Proc Natl Acad Sci USA 94 2 569 574 10.1073/pnas.94.2.569 1:CAS:528:DyaK2sXnslGjtg%3D%3D 9012825 (Pubitemid 27053674)
4. BJ Wouters B Lowenberg CA Erpelinck-Verschueren WL van Putten PJ Valk R Delwel 2009 Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome Blood 113 13 3088 3091 10.1182/blood-2008-09-179895 1:CAS:528:DC%2BD1MXktFWnt74%3D 19171880
5. O Fuchs D Provaznikova M Kocova, et al. 2008 CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma Blood Cells Mol Dis 40 3 401 405 10.1016/j.bcmd.2007.11.005 1:CAS:528:DC%2BD1cXkvFaht70%3D 18182175
6. ML Smith JD Cavenagh TA Lister J Fitzgibbon 2004 Mutation of CEBPA in familial acute myeloid leukemia N Engl J Med 351 23 2403 2407 10.1056/NEJMoa041331 1:CAS:528:DC%2BD2cXhtVCrtrjN 15575056
7. T Nanri N Uike T Kawakita, et al. 2006 A pedigree harboring a germ-line N-terminal C/EBP{alpha} mutation and development of acute myeloblastic leukemia with a somatic C-terminal C/EBP{alpha} mutation Blood 108 11 1916
8. T Pabst M Eyholzer S Haefliger J Schardt BU Mueller 2008 Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia J Clin Oncol 26 31 5088 5093 10.1200/JCO.2008.16.5563 1:CAS:528:DC%2BD1cXhsVGhsrvP 18768433
9. GS Sellick HE Spendlove D Catovsky K Pritchard-Jones RS Houlston 2005 Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia Leukemia 19 7 1276 1278 10.1038/sj.leu.2403788 1:CAS:528:DC%2BD2MXmvVOis7g%3D 15902292 (Pubitemid 40946018)
10. A Renneville V Mialou N Philippe, et al. 2009 Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation Leukemia 23 4 804 806 10.1038/leu.2008.294 1:CAS:528:DC%2BD1MXks1Siurg%3D 18946494
11. C Preudhomme A Renneville V Bourdon, et al. 2009 High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder Blood 113 22 5583 5587 10.1182/blood-2008-07-168260 1:CAS:528:DC%2BD1MXntVerurY%3D 19357396
12. LI Lin CY Chen DT Lin, et al. 2005 Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells Clin Cancer Res 11 4 1372 1379 10.1158/1078-0432.CCR-04-1816 1:CAS:528:DC%2BD2MXhvVSrs7Y%3D 15746035 (Pubitemid 40326229)
13. V Biggio A Renneville O Nibourel, et al. 2008 Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML Leukemia 22 3 655 657 10.1038/sj.leu.2404926 1:CAS:528: DC%2BD1cXjt1Gnsrs%3D 17851556
14. C Resende G Regalo C Duraes F Carneiro JC Machado 2007 Genetic changes of CEBPA in cancer: mutations or polymorphisms? J Clin Oncol 25 17 2493 2494 10.1200/JCO.2007.10.7227 1:CAS:528:DC%2BD2sXns1Kmtbo%3D 17557966 (author reply 4-5) (Pubitemid 46999227)
15. BJ Wouters I Louwers PJ Valk B Lowenberg R Delwel 2007 A recurrent in-frame insertion in a CEBPA transactivation domain is a polymorphism rather than a mutation that does not affect gene expression profiling-based clustering of AML Blood 109 1 389 390 10.1182/blood-2006-08-042325 1:CAS:528: DC%2BD2sXivVyqsrY%3D 17190859 (Pubitemid 46053086)
16. S Fröhling A Corbacioglu R Schlenk H Döhner K Döhner 2007 In reply J Clin Oncol 25 17 2494 2495 10.1200/JCO.2007.11.1195 (Pubitemid 46999228)